Systematic review / meta-analysis / 2023
Flaxseed supplementation significantly reduced HbA1c in patients with type 2 diabetes mellitus.
A systematic review and meta-analysis of 13 randomized controlled trials evaluated the effects of flaxseed supplementation in patients with type 2 diabetes mellitus. Flaxseed supplementation significantly reduced HbA1c compared to control, but had no overall effects on body weight, BMI, blood pressure, fasting blood glucose (FBG), HOMA-IR, QUICKI, or lipid parameters. Subgroup analyses showed significant reductions in FBG in participants with baseline FBG ≥8.0 mmol/L or baseline HbA1c ≥7.0%, and whole flaxseed significantly increased HDL cholesterol and reduced total or LDL cholesterol.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- Patients with type 2 diabetes mellitus across 13 studies
- What was measured
- HbA1c, body weight, BMI, blood pressure, fasting blood glucose, insulin resistance/sensitivity indices, and lipid parameters
THE PAPER
Flaxseed supplementation significantly reduces hemoglobin A1c in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.
Xi H, Zhou W, Sohaib M, Niu Y, Zhu R, Guo Y, Wang S, Mao J, Wang X, Guo L. Nutr Res, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.